Bacillus clausii é classificado como microrganismo probiótico, conhecido também como uma suspensão probiótica aquosa constituída por esporos de bacilos, um microrganismo habitante do intestino sem poder patogênico, que contribui para o equilíbrio da flora intestinal formadora de esporos seguindo intacto ao intestino.

REFERÊNCIAS

  1. Nista EC et al. Bacillus clausii therapy to reduce side-effects of anti-Helicobater pylori treatment: randomized, double-blind, placebo controlled trial. Aliment Pharmacol Ther. 2004 Nov 15;20(10):1181-8

  2. Lahiri K et al. Bacillus clausii As an Adjuvant Therapy in Acute Childhood Diarrhoea. IOSR. 2015a.

  3. Lahiri K et al Benecialrole of probiotics in acute childhood diarrhea. Hormonz. Res. Med. And And Hilth. Sci. 2015b, 2(2), 26-30.

  4. Le H. Duc et al. Charecterization of Bacillius Probiotics Available for Human Use. Applied and environmental microbiology, Apr. 2004, p. 2161-2171

  5. Ghelardi E et al. Survival and persistence of Bacillus clausii in the human gastroinstetinal tract following oral administration as spore-based probiotic formulation. Journal of Applied microbiology 119, 552—59 2015

  6. Puddu, 1980 “Clinical experience with Bacillus Subtilis in children treated with antibiotics”

  7. Mazza et al. The use, of Bacillus Subtilis in children treated with antibiotcs”

  8. Ciffo F. Determination of the Spectrum of Antibiotic Ressitance of the > Strains of Enterogermina. Chemioterapia. Val III-n 1- February 1984.

  9. Abbrescia A et al. Antibiotic Sensitivity of Bacillus clausii Strains in Commercial Preparation Clinical Immunology, Endocrine & Metabolic Drugs, 2014, Vol. 1, No. 2